PFMU
SPRB

Privium Fund Management (UK)’s Spruce Biosciences SPRB Stock Holding History

Privium Fund Management (UK)’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-327
Closed -$12.9K – 161
2024
Q2 		$12.9K Hold
327
– – 0.01% 163
2024
Q1 		$20.1K Hold
327
– – 0.01% 87
2023
Q4 		$71.9K Hold
327
– – 0.05% 74
2023
Q3 		$54.8K Hold
327
– – 0.04% 73
2023
Q2 		$52.1K Hold
327
– – 0.04% 68
2023
Q1 		$52.5K Sell
327
-345
-51% -$64.1K 0.04% 64
2022
Q4 		$55.3K Buy
+672
New +$56.3K 0.04% 53

Other funds holding SPRB

RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Privium Fund Management (UK)'s SPRB Position: Q3 2024 in Review

Privium Fund Management (UK) sold out of Spruce Biosciences (SPRB) in Q3 2024, closing a stake of 327 shares — an estimated $12.9K sold.

Privium Fund Management (UK) first reported a position in SPRB in Q4 2022 and held it in 7 quarters. The position peaked at $71.9K in Q4 2023. 29 funds tracked by Wall St. Rank hold SPRB as of Q3 2024.

  • Privium Fund Management (UK) reported no remaining Spruce Biosciences position as of Q3 2024 after selling out during the quarter.
  • Privium Fund Management (UK) sold 327 Spruce Biosciences shares in Q3 2024, an estimated $12.9K.
  • Privium Fund Management (UK) first reported a position in Spruce Biosciences in Q4 2022 and held it in 7 quarters.
  • Privium Fund Management (UK)'s Spruce Biosciences position peaked at $71.9K in Q4 2023.
  • 29 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2024.

Based on Privium Fund Management (UK)'s 13F filing for Q3 2024, filed 5 Nov 2024.